ATE266633T1 - Neue trisubstituierte phenyl-derivate und analoga - Google Patents

Neue trisubstituierte phenyl-derivate und analoga

Info

Publication number
ATE266633T1
ATE266633T1 AT00983619T AT00983619T ATE266633T1 AT E266633 T1 ATE266633 T1 AT E266633T1 AT 00983619 T AT00983619 T AT 00983619T AT 00983619 T AT00983619 T AT 00983619T AT E266633 T1 ATE266633 T1 AT E266633T1
Authority
AT
Austria
Prior art keywords
analogs
substituted phenyl
phenyl derivatives
new tris
tris
Prior art date
Application number
AT00983619T
Other languages
German (de)
English (en)
Inventor
Maria Boije
Jonas Faegerhag
Alstermark Eva-Lotte Lindstedt
Bengt Ohlsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE266633T1 publication Critical patent/ATE266633T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00983619T 1999-12-03 2000-11-29 Neue trisubstituierte phenyl-derivate und analoga ATE266633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904421A SE9904421D0 (sv) 1999-12-03 1999-12-03 New compounds
PCT/SE2000/002385 WO2001040172A1 (en) 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues

Publications (1)

Publication Number Publication Date
ATE266633T1 true ATE266633T1 (de) 2004-05-15

Family

ID=20417986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00983619T ATE266633T1 (de) 1999-12-03 2000-11-29 Neue trisubstituierte phenyl-derivate und analoga

Country Status (23)

Country Link
US (1) US6750252B2 (enExample)
EP (1) EP1237856B1 (enExample)
JP (1) JP2003515583A (enExample)
KR (1) KR100787072B1 (enExample)
CN (1) CN1206212C (enExample)
AR (1) AR033957A1 (enExample)
AT (1) ATE266633T1 (enExample)
AU (1) AU766533B2 (enExample)
BR (1) BR0016130A (enExample)
CA (1) CA2392039A1 (enExample)
DE (1) DE60010747T2 (enExample)
DK (1) DK1237856T3 (enExample)
ES (1) ES2219425T3 (enExample)
IL (2) IL149517A0 (enExample)
MX (1) MXPA02005223A (enExample)
MY (1) MY124727A (enExample)
NO (1) NO20022590L (enExample)
PT (1) PT1237856E (enExample)
SE (1) SE9904421D0 (enExample)
TR (1) TR200401716T4 (enExample)
TW (1) TWI224590B (enExample)
WO (1) WO2001040172A1 (enExample)
ZA (1) ZA200203798B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2364304B (en) 1997-10-27 2003-04-23 Reddy Research Foundation Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
HUP0101110A3 (en) 1997-10-27 2002-06-28 Reddys Lab Ltd Dr Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
EP1124807A1 (en) 1997-10-27 2001-08-22 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
BR9914438A (pt) 1998-10-29 2001-06-26 Reddy Research Foundation Processo aperfeiçoado para a preparação de novos agentes anti-diabéticos
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
SE0101386D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
PL369732A1 (en) * 2001-10-16 2005-05-02 Dr.Reddy's Laboratories Ltd. Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
WO2007137260A2 (en) * 2006-05-22 2007-11-29 Elan Pharmaceuticals, Inc. Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu' s reaction
KR101558005B1 (ko) 2007-03-08 2015-10-06 알비레오 에이비 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도
FR2917084B1 (fr) 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2917086B1 (fr) * 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
KR20020067537A (ko) 2002-08-22
CA2392039A1 (en) 2001-06-07
NO20022590D0 (no) 2002-05-31
DE60010747T2 (de) 2005-05-19
DK1237856T3 (da) 2004-08-02
EP1237856B1 (en) 2004-05-12
US6750252B2 (en) 2004-06-15
MXPA02005223A (es) 2003-09-25
TWI224590B (en) 2004-12-01
IL149517A (en) 2007-07-04
IL149517A0 (en) 2002-11-10
CN1402703A (zh) 2003-03-12
EP1237856A1 (en) 2002-09-11
WO2001040172A1 (en) 2001-06-07
ZA200203798B (en) 2003-10-29
US20030149104A1 (en) 2003-08-07
AR033957A1 (es) 2004-01-21
AU2035101A (en) 2001-06-12
KR100787072B1 (ko) 2007-12-21
TR200401716T4 (tr) 2004-09-21
ES2219425T3 (es) 2004-12-01
SE9904421D0 (sv) 1999-12-03
JP2003515583A (ja) 2003-05-07
CN1206212C (zh) 2005-06-15
AU766533B2 (en) 2003-10-16
MY124727A (en) 2006-06-30
BR0016130A (pt) 2002-08-20
NO20022590L (no) 2002-07-29
DE60010747D1 (de) 2004-06-17
PT1237856E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
ATE266633T1 (de) Neue trisubstituierte phenyl-derivate und analoga
DE69911770D1 (de) Neue 3-aryl-propionsäurederivate und analoge
EE9900540A (et) Omeprasooli ravimvorm
DE60039206D1 (de) Neue Quinazolin-Derivate
DE69821423D1 (de) Nichtreziproke Schaltungsanordnung
ID23338A (id) Popok tarik sekali pakai
FI973816A0 (fi) Polypropen med hoeg smaeltstyrka
NO993658D0 (no) Sulfonylurea-derivater
FI991485A0 (fi) Uusi farmaseuttinen koostumus
DE69936008D1 (de) Keramischer Kondensator
IS5760A (is) Meðferðarlegar bíarýl afleiður
DK1104422T3 (da) Phenylxanthinderivater
ID23198A (id) Popok tarik sekali pakai
DE60007530D1 (de) Oral wirksame androgene
DE60043058D1 (de) Dentalwerkstoffe
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
NO985937D0 (no) Dentalt implantatsystem med forbedret stabilitet
FI974001A0 (fi) Nya metylenbisfosfonsyraderivat
DK1019042T3 (da) Forbindelser med anti-første-passagevirkning
FI973645A0 (fi) Foerfarande foer bestaemning av filtreringstiderna foer registeraoteranrop i ett telekommunikationssystem i samband med en V5-anslutning i olika nationella tillaempningar
DE60008950D1 (de) Keramikzusammensetzung
DE60001464T2 (de) Neue zusammensetzung und emulgiermittel
NO996391D0 (no) Angiogenese-inhiberende tiadiazolylpyridazinderivater
FI970017A0 (fi) Med lampeffekts maetning foersett reglerbart elektroniskt anslutningsorgan
DE69816497D1 (de) Nichtreziproke Schaltungsanordnung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237856

Country of ref document: EP

REN Ceased due to non-payment of the annual fee